Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Couchbase, Inc.BASE · Entity 74989 | 10% owner | July 26, 2021 | July 26, 2021 |
| Lyra Therapeutics, Inc.LYRA · Entity 46837 | 10% owner | May 31, 2023 | June 02, 2023 |
| Markforged Holding CorpMKFG · Entity 80484 | 10% owner | July 14, 2021 | July 14, 2021 |
| VEECO INSTRUMENTS INCVECO · Entity 4322 | Director | May 14, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Couchbase, Inc.
Report date July 26, 2021 · Filed July 26, 2021
Jointly reported with NBVM GP, LLC, North Bridge Venture Partners 7, L.P., North Bridge Venture Partners VI L P, North Bridge Venture Management VI, L.P., North Bridge Venture Management 7, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy: North Bridge Venture Partners 7, L.P. | 2,689,172 |
Last balance in matching sequence
After 2021-07-26 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-07-26 · Conversion · Acquired 2,402,147 · Balance 2,594,381 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Row 3 · 2021-07-26 · Purchase · Acquired 94,791 · Balance 2,689,172 F4: In connection with the Issuer's initial public offering of Common Stock, NBVP 7 purchased additional shares of Common Stock from the underwriters at the initial public offering price as set forth herein. F2: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectBy: North Bridge Venture Partners VI, L.P. | 1,987,084 |
Last balance in matching sequence
After 2021-07-26 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2021-07-26 · Conversion · Acquired 1,864,081 · Balance 1,946,459 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Row 4 · 2021-07-26 · Purchase · Acquired 40,625 · Balance 1,987,084 F5: In connection with the Issuer's initial public offering of Common Stock, NBVP VI purchased additional shares of Common Stock from the underwriters at the initial public offering price as set forth herein. F3: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series A Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners 7, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-07-26 · Conversion · Disposed 643,708 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series A Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners VI, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-07-26 · Conversion · Disposed 643,708 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners 7, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-07-26 · Conversion · Disposed 498,927 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners VI, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-07-26 · Conversion · Disposed 498,927 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners 7, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-07-26 · Conversion · Disposed 317,901 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners VI, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-07-26 · Conversion · Disposed 317,901 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series D Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners 7, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2021-07-26 · Conversion · Disposed 201,031 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series D Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners VI, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2021-07-26 · Conversion · Disposed 86,156 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series E Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners 7, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2021-07-26 · Conversion · Disposed 93,999 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series E Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners VI, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2021-07-26 · Conversion · Disposed 40,285 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series F Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners 7, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2021-07-26 · Conversion · Disposed 131,840 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series F Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners VI, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2021-07-26 · Conversion · Disposed 56,502 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series G Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners 7, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2021-07-26 · Conversion · Disposed 477,888 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Series G Preferred StockSEC Table II · derivative / convertible security | IndirectBy: North Bridge Venture Partners VI, L.P. | 0 |
Reported balance
After 2021-07-26 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2021-07-26 · Conversion · Disposed 204,809 · Balance 0 F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date.
F2: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
F3: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
F4: In connection with the Issuer's initial public offering of Common Stock, NBVP 7 purchased additional shares of Common Stock from the underwriters at the initial public offering price as set forth herein.
F5: In connection with the Issuer's initial public offering of Common Stock, NBVP VI purchased additional shares of Common Stock from the underwriters at the initial public offering price as set forth herein.
Lyra Therapeutics, Inc.
Report date May 31, 2023 · Filed June 02, 2023
Jointly reported with NBVM GP, LLC, NORTH BRIDGE VENTURE PARTNERS V A LP, NORTH BRIDGE VENTURE PARTNERS V-B LP, North Bridge Venture Partners VI L P, North Bridge Venture Management V, L.P., North Bridge Venture Management VI, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 2,259,301 |
Reported balance
After 2023-05-31 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2023-05-31 · Purchase · Acquired 403,858 · Balance 2,259,301 F1: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F2: The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,107,370 |
Reported balance
After 2023-05-31 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2023-05-31 · Purchase · Acquired 197,946 · Balance 1,107,370 F1: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F3: The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 2,521,745 |
Reported balance
After 2023-05-31 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2023-05-31 · Purchase · Acquired 1,203,612 · Balance 2,521,745 F1: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F4: The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Warrant to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.67 · Expires 2028-11-30 | IndirectSee footnote | 201,929 |
Reported balance
After 2023-05-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-05-31 · Purchase · Acquired 201,929 · Balance 201,929 F1: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F2: The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Warrant to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.67 · Expires 2028-11-30 | IndirectSee footnote | 98,973 |
Reported balance
After 2023-05-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-05-31 · Purchase · Acquired 98,973 · Balance 98,973 F1: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F3: The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
| Warrant to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.67 · Expires 2028-11-30 | IndirectSee footnote | 601,806 |
Reported balance
After 2023-05-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-05-31 · Purchase · Acquired 601,806 · Balance 601,806 F1: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F4: The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors.
F2: The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
F3: The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
F4: The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
Markforged Holding Corp
Report date July 14, 2021 · Filed July 14, 2021
Jointly reported with NBVM GP, LLC, North Bridge Venture Partners 7, L.P., North Bridge Venture Management 7, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy North Bridge Venture Partners 7, L.P. | 29,126,742 |
Reported balance
Holding disclosure · report date 2021-07-14 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 29,126,742 F1: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7 LP"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7 L.P. NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors post-closing of the Business Combination (as defined in footnote 2 below), and Richard A. D'Amore are the managers of NVBM GP (collectively, the "Managers"). Each of NBVM 7, NBVM GP and the Managers may be deemed to have shared voting and dispositive power over the shares held by NBVP 7 LP. Each of NBVM 7, NBVM GP and the Managers disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any one of them is the beneficial owner of such shares for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein, if any. |
| Earnout SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-07-14 | IndirectBy North Bridge Venture Partners 7, L.P. | Not disclosed |
Reported balance
Holding disclosure · report date 2021-07-14 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F2: On July 14, 2021 (the "Closing Date") one, the Issuer's predecessor, consummated the business combination (the "Business Combination") pursuant to the terms of the merger agreement dated as of February 23, 2021 by and among one, Caspian Merger Sub Inc., a Delaware corporation and MarkForged, Inc., a Delaware corporation. F3: Immediately prior to the effective time of the Business Combination on the Closing Date, NBVP 7 LP received the right to acquire 2,633,246 shares of the Issuer's Common Stock in connection with the Business Combination, (i) 1,436,316 of which will be released from escrow if the volume-weighted average price ("VWAP") of the Issuer for any 20 trading days in a consecutive 30-trading day period following the Closing Date is at least $12.50; and (ii) 1,196,930 of which will be released from escrow if the VWAP for any 20 trading days in a consecutive 30-day trading period following the Closing Date is at least $15.00. Upon a change of control or liquidation of the Issuer all such previously unearned shares will be issued. Any shares not eligible to be released within five years of the Closing Date will be forfeited and canceled. F1: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7 LP"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7 L.P. NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors post-closing of the Business Combination (as defined in footnote 2 below), and Richard A. D'Amore are the managers of NVBM GP (collectively, the "Managers"). Each of NBVM 7, NBVM GP and the Managers may be deemed to have shared voting and dispositive power over the shares held by NBVP 7 LP. Each of NBVM 7, NBVM GP and the Managers disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any one of them is the beneficial owner of such shares for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7 LP"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7 L.P. NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors post-closing of the Business Combination (as defined in footnote 2 below), and Richard A. D'Amore are the managers of NVBM GP (collectively, the "Managers"). Each of NBVM 7, NBVM GP and the Managers may be deemed to have shared voting and dispositive power over the shares held by NBVP 7 LP. Each of NBVM 7, NBVM GP and the Managers disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any one of them is the beneficial owner of such shares for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein, if any.
F2: On July 14, 2021 (the "Closing Date") one, the Issuer's predecessor, consummated the business combination (the "Business Combination") pursuant to the terms of the merger agreement dated as of February 23, 2021 by and among one, Caspian Merger Sub Inc., a Delaware corporation and MarkForged, Inc., a Delaware corporation.
F3: Immediately prior to the effective time of the Business Combination on the Closing Date, NBVP 7 LP received the right to acquire 2,633,246 shares of the Issuer's Common Stock in connection with the Business Combination, (i) 1,436,316 of which will be released from escrow if the volume-weighted average price ("VWAP") of the Issuer for any 20 trading days in a consecutive 30-trading day period following the Closing Date is at least $12.50; and (ii) 1,196,930 of which will be released from escrow if the VWAP for any 20 trading days in a consecutive 30-day trading period following the Closing Date is at least $15.00. Upon a change of control or liquidation of the Issuer all such previously unearned shares will be issued. Any shares not eligible to be released within five years of the Closing Date will be forfeited and canceled.
VEECO INSTRUMENTS INC
Report date May 14, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 112,594 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Sale · Disposed 43,701 · Balance 112,594 F1: Reflects average weighted sale price. Actual sale prices ranged from $60.42 to $61.15 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects average weighted sale price. Actual sale prices ranged from $60.42 to $61.15 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EVERBRIDGE, INC.
Report date July 02, 2024 · Filed July 02, 2024
Section 16 reporting ended · disclosed 2024-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-07-02 transaction · row 1
1 source rowRow 1 · 2024-07-02 · Disposition to issuer · Disposed 25,415 · Balance 0 F1: On July 2, 2024, Project Emerson Merger Sub, Inc. ("Merger Sub") completed its merger (the "Merger") with and into the Issuer pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of February 29, 2024 (the "Merger Agreement"), by and among the Issuer, Everbridge Holdings, LLC (formerly known as Project Emerson Parent, LLC) ("Parent"), and Merger Sub, which amends and restates that certain Agreement and Plan of Merger, dated as of February 4, 2024, by and among the Issuer, Parent and Merger Sub. F2: At the effective time of the Merger (the "Effective Time"), each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $35.00, without interest, subject to the terms and conditions of the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 2, 2024, Project Emerson Merger Sub, Inc. ("Merger Sub") completed its merger (the "Merger") with and into the Issuer pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of February 29, 2024 (the "Merger Agreement"), by and among the Issuer, Everbridge Holdings, LLC (formerly known as Project Emerson Parent, LLC) ("Parent"), and Merger Sub, which amends and restates that certain Agreement and Plan of Merger, dated as of February 4, 2024, by and among the Issuer, Parent and Merger Sub.
F2: At the effective time of the Merger (the "Effective Time"), each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $35.00, without interest, subject to the terms and conditions of the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 18, 2026 21:27 UTC | VEECO INSTRUMENTS INC VECO · Entity 4322 | SaleCommon Stock | 43,701 | $60.71 | $2,653,087.71 |
DisclosureSEC source: 0001206641-26-000004 · form4-05182026_090524.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,594 F1 · price: Reflects average weighted sale price. Actual sale prices ranged from $60.42 to $61.15 per share. The reporting person undertakes to provide, upon the request of the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:35 UTC | VEECO INSTRUMENTS INC VECO · Entity 4322 | GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001206641-26-000002 · form4-05112026_040501.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,295 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2027 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| May 09, 2025 Filed May 9, 2025 20:25 UTC | VEECO INSTRUMENTS INC VECO · Entity 4322 | GrantCommon Stock | 8,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012510 · form4-05092025_040501.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,350 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2026 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| July 02, 2024 Filed Jul 2, 2024 17:28 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | Disposition to issuerCommon Stock | 25,415 | $35.00 | $889,525.00 |
DisclosureSEC source: 0000950170-24-080781 · ownership.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: On July 2, 2024, Project Emerson Merger Sub, Inc. ("Merger Sub") completed its merger (the "Merger") with and into the Issuer pursuant to the Amended and Restated Agreement and Plan of Merger, dated as of February 29, 2024 (the "Merger Agreement"), by and among the Issuer, Everbridge Holdings, LLC (formerly known as Project Emerson Parent, LLC) ("Parent"), and Merger Sub, which amends and restates that certain Agreement and Plan of Merger, dated as of February 4, 2024, by and among the Issuer, Parent and Merger Sub. F2 · price: At the effective time of the Merger (the "Effective Time"), each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $35.00, without interest, subject to the terms and conditions of the Merger Agreement. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:15 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionRestricted Stock Unit · Derivative | 8,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015327 · form4-06042024_040604.xml · derivative · entry 2 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,068 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The RSUs vested on May 31, 2024. F2 · derivative.expiration_date: The RSUs vested on May 31, 2024. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:15 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionCommon Stock | 8,068 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-015327 · form4-06042024_040604.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. Read SEC document |
| May 10, 2024 Filed May 10, 2024 20:35 UTC | VEECO INSTRUMENTS INC VECO · Entity 4322 | GrantCommon Stock | 3,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012879 · form4-05102024_040502.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,059 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2025 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 17:45 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | PurchaseCommon Stock | 11,000 | $22.39 | $246,279.00 |
DisclosureSEC source: 0001209191-23-045689 · doc4.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,347 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.21 to $22.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 16:15 UTC | Lyra Therapeutics, Inc. LYRA · Entity 46837 | PurchaseWarrant to purchase Common Stock · Derivative | 601,806 | $0.13 Strike: $2.67 | $75,225.75 |
DisclosureSEC source: 0000899243-23-014352 · doc4.xml · derivative · entry 6 NBVM GP, LLC · CIK 0001401650 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner NORTH BRIDGE VENTURE PARTNERS V A LP · CIK 0001138402 · 10% owner NORTH BRIDGE VENTURE PARTNERS V-B LP · CIK 0001138399 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management V, L.P. · CIK 0001297397 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 601,806 Underlying: Common Stock · 601,806 shares Expires 2028-11-30 F1 · kind: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F4 · ownership.nature: The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 16:15 UTC | Lyra Therapeutics, Inc. LYRA · Entity 46837 | PurchaseWarrant to purchase Common Stock · Derivative | 98,973 | $0.13 Strike: $2.67 | $12,371.63 |
DisclosureSEC source: 0000899243-23-014352 · doc4.xml · derivative · entry 5 NBVM GP, LLC · CIK 0001401650 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner NORTH BRIDGE VENTURE PARTNERS V A LP · CIK 0001138402 · 10% owner NORTH BRIDGE VENTURE PARTNERS V-B LP · CIK 0001138399 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management V, L.P. · CIK 0001297397 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 98,973 Underlying: Common Stock · 98,973 shares Expires 2028-11-30 F1 · kind: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F3 · ownership.nature: The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 16:15 UTC | Lyra Therapeutics, Inc. LYRA · Entity 46837 | PurchaseWarrant to purchase Common Stock · Derivative | 201,929 | $0.13 Strike: $2.67 | $25,241.13 |
DisclosureSEC source: 0000899243-23-014352 · doc4.xml · derivative · entry 4 NBVM GP, LLC · CIK 0001401650 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner NORTH BRIDGE VENTURE PARTNERS V A LP · CIK 0001138402 · 10% owner NORTH BRIDGE VENTURE PARTNERS V-B LP · CIK 0001138399 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management V, L.P. · CIK 0001297397 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 201,929 Underlying: Common Stock · 201,929 shares Expires 2028-11-30 F1 · kind: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F2 · ownership.nature: The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 16:15 UTC | Lyra Therapeutics, Inc. LYRA · Entity 46837 | PurchaseCommon Stock | 1,203,612 | $2.43 | $2,924,777.16 |
DisclosureSEC source: 0000899243-23-014352 · doc4.xml · nonDerivative · entry 3 NBVM GP, LLC · CIK 0001401650 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner NORTH BRIDGE VENTURE PARTNERS V A LP · CIK 0001138402 · 10% owner NORTH BRIDGE VENTURE PARTNERS V-B LP · CIK 0001138399 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management V, L.P. · CIK 0001297397 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,521,745 F1 · kind: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F4 · ownership.nature: The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 16:15 UTC | Lyra Therapeutics, Inc. LYRA · Entity 46837 | PurchaseCommon Stock | 197,946 | $2.43 | $481,008.78 |
DisclosureSEC source: 0000899243-23-014352 · doc4.xml · nonDerivative · entry 2 NBVM GP, LLC · CIK 0001401650 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner NORTH BRIDGE VENTURE PARTNERS V A LP · CIK 0001138402 · 10% owner NORTH BRIDGE VENTURE PARTNERS V-B LP · CIK 0001138399 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management V, L.P. · CIK 0001297397 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,107,370 F1 · kind: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F3 · ownership.nature: The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 16:15 UTC | Lyra Therapeutics, Inc. LYRA · Entity 46837 | PurchaseCommon Stock | 403,858 | $2.43 | $981,374.94 |
DisclosureSEC source: 0000899243-23-014352 · doc4.xml · nonDerivative · entry 1 NBVM GP, LLC · CIK 0001401650 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner NORTH BRIDGE VENTURE PARTNERS V A LP · CIK 0001138402 · 10% owner NORTH BRIDGE VENTURE PARTNERS V-B LP · CIK 0001138399 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management V, L.P. · CIK 0001297397 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,259,301 F1 · kind: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F2 · ownership.nature: The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 16:14 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionRestricted Stock Unit · Derivative | 4,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033685 · doc4.xml · derivative · entry 2 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,176 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Everbridge common stock F2 · derivative.exercise_date: On May 19, 2022 the reporting person was granted restricted stock units (RSUs). The RSUs vested on May 31, 2023. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 16:14 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionCommon Stock | 4,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-033685 · doc4.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Everbridge common stock Read SEC document |
| May 25, 2023 Filed May 26, 2023 16:09 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | GrantRestricted Stock Unit · Derivative | 8,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032497 · doc4.xml · derivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,068 Underlying: Common Stock · 8,068 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Everbridge common stock. F2 · derivative.exercise_date: Represents a restricted stock unit ("RSU") grant. Each RSU represents the contingent right to receive one share of Issuer common stock. 100% of the RSUs will vest on May 25, 2024, or the next annual shareholder meeting, subject to the Reporting Person remaining in the service of Issuer through the vesting date. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 12, 2023 Filed May 15, 2023 20:28 UTC | VEECO INSTRUMENTS INC VECO · Entity 4322 | GrantCommon Stock | 6,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-007987 · form4-05152023_080539.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,382 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2024 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 16:45 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionRestricted Stock Unit · Derivative | 1,448 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033559 · doc4.xml · derivative · entry 2 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,448 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 20, 2021 the reporting person was granted restricted stock units (RSUs). The RSUs vested on May 31, 2022. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 16:45 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionCommon Stock | 1,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-033559 · doc4.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 31, 2022 Filed Jun 2, 2023 16:10 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionRestricted Stock Unit · Derivative | 4,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033678 · doc4.xml · derivative · entry 2 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,176 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Everbridge common stock F2 · derivative.exercise_date: On May 19, 2022 the reporting person was granted restricted stock units (RSUs). The RSUs vested on May 31, 2023. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 31, 2022 Filed Jun 2, 2023 16:10 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionCommon Stock | 4,176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-033678 · doc4.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Everbridge common stock Read SEC document |
| May 19, 2022 Filed May 23, 2022 17:20 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | GrantRestricted Stock Unit · Derivative | 4,176 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031390 · doc4.xml · derivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,176 Underlying: Common Stock · 4,176 shares Expires not disclosed F1 · derivative.exercise_date: Represents a grant of restricted stock units under the Everbridge, Inc. 2016 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Everbridge common stock. Subject to accelerated vesting in certain circumstances, the restricted stock units are scheduled to vest last day of the month after the date of the 2023 annual meeting of stockholders of Everbridge, as long as the reporting person remains in the service of Everbridge through the respective vesting date. F2 · derivative.expiration_date: Not applicable. Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:37 UTC | VEECO INSTRUMENTS INC VECO · Entity 4322 | GrantCommon Stock | 6,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005144 · form4-05172022_010539.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,622 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2023 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 16:14 UTC | Lyra Therapeutics, Inc. LYRA · Entity 46837 | PurchaseCommon Stock | 765,010 | $4.22 | $3,228,342.20 |
DisclosureSEC source: 0000899243-22-014796 · doc4.xml · nonDerivative · entry 3 NBVM GP, LLC · CIK 0001401650 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner NORTH BRIDGE VENTURE PARTNERS V A LP · CIK 0001138402 · 10% owner NORTH BRIDGE VENTURE PARTNERS V-B LP · CIK 0001138399 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management V, L.P. · CIK 0001297397 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,318,133 F1 · kind: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated April 7, 2022 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F4 · ownership.nature: The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 16:14 UTC | Lyra Therapeutics, Inc. LYRA · Entity 46837 | PurchaseCommon Stock | 527,806 | $4.22 | $2,227,341.32 |
DisclosureSEC source: 0000899243-22-014796 · doc4.xml · nonDerivative · entry 2 NBVM GP, LLC · CIK 0001401650 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner NORTH BRIDGE VENTURE PARTNERS V A LP · CIK 0001138402 · 10% owner NORTH BRIDGE VENTURE PARTNERS V-B LP · CIK 0001138399 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management V, L.P. · CIK 0001297397 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 909,424 F1 · kind: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated April 7, 2022 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F3 · ownership.nature: The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 16:14 UTC | Lyra Therapeutics, Inc. LYRA · Entity 46837 | PurchaseCommon Stock | 1,076,851 | $4.22 | $4,544,311.22 |
DisclosureSEC source: 0000899243-22-014796 · doc4.xml · nonDerivative · entry 1 NBVM GP, LLC · CIK 0001401650 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner NORTH BRIDGE VENTURE PARTNERS V A LP · CIK 0001138402 · 10% owner NORTH BRIDGE VENTURE PARTNERS V-B LP · CIK 0001138399 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management V, L.P. · CIK 0001297397 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,855,443 F1 · kind: The reportable securities were acquired pursuant to the Securities Purchase Agreement dated April 7, 2022 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors. F2 · ownership.nature: The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries G Preferred Stock · Derivative | 204,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 18 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners VI, L.P. Disclosed balance after: 0 Underlying: Common Stock · 218,476 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries G Preferred Stock · Derivative | 477,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 17 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners 7, L.P. Disclosed balance after: 0 Underlying: Common Stock · 509,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries F Preferred Stock · Derivative | 56,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 16 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners VI, L.P. Disclosed balance after: 0 Underlying: Common Stock · 56,502 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries F Preferred Stock · Derivative | 131,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 15 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners 7, L.P. Disclosed balance after: 0 Underlying: Common Stock · 131,840 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries E Preferred Stock · Derivative | 40,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 14 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners VI, L.P. Disclosed balance after: 0 Underlying: Common Stock · 42,411 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries E Preferred Stock · Derivative | 93,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 13 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners 7, L.P. Disclosed balance after: 0 Underlying: Common Stock · 98,962 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries D Preferred Stock · Derivative | 86,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 12 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners VI, L.P. Disclosed balance after: 0 Underlying: Common Stock · 86,156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries D Preferred Stock · Derivative | 201,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 11 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners 7, L.P. Disclosed balance after: 0 Underlying: Common Stock · 201,031 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries C Preferred Stock · Derivative | 317,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 10 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners VI, L.P. Disclosed balance after: 0 Underlying: Common Stock · 317,901 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries C Preferred Stock · Derivative | 317,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 9 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners 7, L.P. Disclosed balance after: 0 Underlying: Common Stock · 317,901 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries B Preferred Stock · Derivative | 498,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 8 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners VI, L.P. Disclosed balance after: 0 Underlying: Common Stock · 498,927 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries B Preferred Stock · Derivative | 498,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 7 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners 7, L.P. Disclosed balance after: 0 Underlying: Common Stock · 498,927 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries A Preferred Stock · Derivative | 643,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 6 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners VI, L.P. Disclosed balance after: 0 Underlying: Common Stock · 643,708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionSeries A Preferred Stock · Derivative | 643,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · derivative · entry 5 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners 7, L.P. Disclosed balance after: 0 Underlying: Common Stock · 643,708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | PurchaseCommon Stock | 40,625 | $24.00 | $975,000.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · nonDerivative · entry 4 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners VI, L.P. Disclosed balance after: 1,987,084 F5 · shares: In connection with the Issuer's initial public offering of Common Stock, NBVP VI purchased additional shares of Common Stock from the underwriters at the initial public offering price as set forth herein. F3 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | PurchaseCommon Stock | 94,791 | $24.00 | $2,274,984.00 |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · nonDerivative · entry 3 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners 7, L.P. Disclosed balance after: 2,689,172 F4 · shares: In connection with the Issuer's initial public offering of Common Stock, NBVP 7 purchased additional shares of Common Stock from the underwriters at the initial public offering price as set forth herein. F2 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionCommon Stock | 1,864,081 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · nonDerivative · entry 2 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners VI, L.P. Disclosed balance after: 1,946,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F3 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI, and NBVM GP is the sole general partner of NBVM VI. The Managing Members are the managers of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 26, 2021 Filed Jul 26, 2021 21:36 UTC | Couchbase, Inc. BASE · Entity 74989 | ConversionCommon Stock | 2,402,147 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-048264 · doc4.xml · nonDerivative · entry 1 NBVM GP, LLC · CIK 0001401650 · 10% owner North Bridge Venture Partners 7, L.P. · CIK 0001853158 · 10% owner DAMORE RICHARD A · CIK 0001206641 · 10% owner North Bridge Venture Partners VI L P · CIK 0001327539 · 10% owner North Bridge Venture Management VI, L.P. · CIK 0001590898 · 10% owner North Bridge Venture Management 7, L.P. · CIK 0001853157 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: North Bridge Venture Partners 7, L.P. Disclosed balance after: 2,594,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series F Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series E Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.05279880234039-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. Each share of Series G Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1.06673317089756-for-one basis immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The reportable securities are owned directly by North Bridge Venture Partners 7, L.P. ("NBVP 7"). North Bridge Venture Management 7, L.P. ("NBVM 7") is the sole general partner of NBVP 7, and NBVM GP, LLC ("NBVM GP") is the sole general partner of NBVM 7. Each of Edward T. Anderson, a member of the Issuer's board of directors, and Richard A. D'Amore are the managing members of NBVM GP (collectively, the "Managing Members") and may be deemed to have shared voting and dispositive power over the shares held by NBVP 7. Each of NBVM 7, NBVM GP and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 31, 2021 Filed Jun 2, 2021 16:38 UTC Amendment | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionRestricted Stock Unit · Derivative | 723 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037219 · doc4a.xml · derivative · entry 2 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 723 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 13, 2020, the reporting person was granted restricted stock units (RSUs). The RSUs vested on May 31, 2021. F3 · derivative.expiration_date: Not applicable Read SEC document |
| May 31, 2021 Filed Jun 2, 2021 16:38 UTC Amendment | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionCommon Stock | 723 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037219 · doc4a.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 31, 2021 Filed Jun 2, 2021 16:31 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | Exercise / conversionRestricted Stock Unit · Derivative | 723 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037195 · doc4.xml · derivative · entry 2 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 723 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 13, 2020, the reporting person was granted restricted stock units (RSUs). The RSUs vested on May 31, 2021. F3 · derivative.expiration_date: Not applicable Read SEC document |
| May 20, 2021 Filed May 24, 2021 17:10 UTC | EVERBRIDGE, INC. EVBG · Entity 89241 | GrantRestricted Stock Unit · Derivative | 1,448 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035422 · doc4.xml · derivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,448 Underlying: Common Stock · 1,448 shares Expires not disclosed F1 · derivative.exercise_date: Represents a grant of restricted stock units under the Everbridge, Inc. 2016 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Everbridge common stock. Subject to accelerated vesting in certain circumstances, the restricted stock units are scheduled to vest last day of the month after the date of the 2022 annual meeting of stockholders of Everbridge, as long as the reporting person remains in the service of Everbridge through the respective vesting date. F2 · derivative.expiration_date: Not applicable. Read SEC document |
| May 07, 2021 Filed May 10, 2021 20:41 UTC | VEECO INSTRUMENTS INC VECO · Entity 4322 | GrantCommon Stock | 5,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005059 · edgar.xml · nonDerivative · entry 1 DAMORE RICHARD A · CIK 0001206641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,031 F1 · shares: These shares were awarded as restricted stock pursuant to the Veeco Instruments Inc. 2019 Stock Incentive Plan in consideration of services as a director. These shares are subject to certain restrictions which shall lapse on the earlier to occur of: (i) the date immediately preceding the date of the Company's 2022 Annual Meeting of stockholders and (ii) the first anniversary of the award date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.